Companiesandmarkets.com

Global OTC pharmaceutical market: 2% CAGR between 2012 and 2016

Press Release   •   Feb 25, 2013 11:52 GMT

The Global Over-the-counter (OTC) Pharmaceutical market is to grow at a CAGR of 1.9 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing switch from prescription to OTC drugs. The Global Over-the-counter Pharmaceutical market has also been witnessing the trend of an increasing number of mergers and acquisitions. However, the increasing risks of side-effects could pose a challenge to the growth of this market.

Mergers and acquisitions help vendors grow rapidly and expand their business. The Global Over-the-counter (OTC) Pharmaceuticals market is nowadays witnessing an increase in mergers and acquisitions among vendors. For instance, Sanofi acquired US-based Chattem Chemicals Inc., a leading manufacturer of branded consumer healthcare products, toiletries, and dietary supplements. This acquisition will increase the company's share in the Consumer Healthcare market in the US. Similarly, JandJ acquired Synthes Inc. in June 2012 to strengthen its orthopedics business and its position in developing countries.

One of the key factors driving the Global OTC Pharmaceuticals market is the increasing switch from prescription drugs to OTC drugs. Since OTC drugs are cost-effective, they help cut down the overall healthcare costs. Moreover, there is a trend to move some drugs from prescription category to OTC category as part of product lifecycle management. Furthermore, many consumers prefer OTC drugs because of their easy availability. Some patients prefer OTC drugs to avoid visiting a doctor. The OTC Drug market in the US grew tremendously in 2011 because of the launch of the OTC version of the drug Allegra, which is Sanofi's major allergy relief drug. Thus, increasing switch from prescription to OTC drugs has increased the demand for OTC drugs significantly.

The key vendors dominating this market space are Bayer Healthcare AG, Johnson and Johnson, GlaxoSmithKline plc, and Novartis International AG. The other vendors mentioned in the report are Sanofi S.A., Reckitt Benckiser plc, Boehringer Ingelheim GmbH , Merck and Co. Inc., Pfizer Inc., Takeda Pharmaceutical Co. Ltd., Roche Holding Ltd., Procter and Gamble, Taisho Pharmaceutical, Bristol Myers Squibb Co., Schering-Plough Corp., Eisai Co. Ltd., Mitsubishi Tanabe Pharma Corp., Sigma Pharmaceuticals plc, Hubei Biocause Heilen Pharmaceutical Co. Ltd., United Laboratories Inc., Daewoong Pharmaceutical Co. Ltd., Bukwang Pharmaceutical Co. Ltd., Vida Laboratories Ltd., and Cipla Ltd.

For more information on the Global OTC pharmaceutical market, please click here: Global OTC pharmaceutical market

For more information on the Healthcare and Medical market, please click here: Healthcare and Medical Reports

Companiesandmarkets.com issues news updates and report summaries covering all major industries and sectors. The service provides additional client monitoring and timely alerts to breaking industry and sector news leading the day's business headlines. News articles, written by our staff, contain additional analyst insight, providing value added insight for our readers. News updates and real-time alerts on newly-released market reports are also available from our Facebook page, Twitter feed @CandMResearch and RSS links. We also welcome inquiries from business journalists and the news media.